<?xml version="1.0" encoding="UTF-8"?>
<p>On the other hand, many chalcone derivatives (compound 
 <bold>1</bold>
 <xref rid="CIT0047" ref-type="bibr">
  <sup>47</sup>
 </xref>, compound 
 <bold>2</bold>
 <xref rid="CIT0048" ref-type="bibr">
  <sup>48</sup>
 </xref>, and compound 
 <bold>3</bold>
 <xref rid="CIT0049" ref-type="bibr">
  <sup>49</sup>
 </xref>) along with pyrazole derivatives (compound 
 <bold>4</bold>
 <xref rid="CIT0050" ref-type="bibr">
  <sup>50</sup>
 </xref> and compound 
 <bold>5</bold>
 <xref rid="CIT0051" ref-type="bibr">
  <sup>51</sup>
 </xref>) and piperazine derivatives (compound 
 <bold>6</bold>
 <xref rid="CIT0052" ref-type="bibr">
  <sup>52</sup>
 </xref> and compound 
 <bold>7</bold>
 <xref rid="CIT0053" ref-type="bibr">
  <sup>53</sup>
 </xref>) display potential inhibitory activity of VEGFR-2 kinase which is an essential factor in angiogenesis (
 <xref ref-type="fig" rid="F0001">Figure 1</xref>). Thus, chalcone and analogues demonstrated potential inhibitory activity of VEGFR could be considered as important cancer prevention targets
 <xref rid="CIT0054" ref-type="bibr">
  <sup>54â€“56</sup>
 </xref>.
</p>
